Presumptive precursor-targeted immune-mediated anemia concurrent with gastrointestinal lymphoma in a cat

Makoto Akiyoshi1,2, Masaharu Hisasue1, Sakurako Neo3

  • 1Laboratory of Small Animal Internal Medicine, Azabu University, Sagamihara-shi, 1-17-71 Fuchinobe, Chuuku, Sagamihara-shi, Kanagawa 252-5201, Japan.

Insights

This case report details a cat with precursor-targeted immune-mediated anemia (PIMA) and concurrent T-cell lymphoma. Successful treatment involved surgery and immunosuppression, with no recurrence observed.

Area of Science:

  • Veterinary Medicine
  • Immunology
  • Oncology

Background:

  • Nonregenerative anemia is a common clinical sign in cats.
  • Immune-mediated hemolytic anemia (IMHA) can occur in felines.
  • Gastrointestinal lymphoma is a known neoplastic condition in cats.

Observation:

  • A 10-year-old cat presented with severe nonregenerative anemia and a gastric mass.
  • Bone marrow analysis showed erythroid precursors phagocytized by macrophages.
  • The gastric mass was diagnosed as CD20-positive T-cell lymphoma.

Findings:

  • The cat was diagnosed with presumptive precursor-targeted immune-mediated anemia (PIMA).
  • Surgical resection of the lymphoma and immunosuppressive therapy resolved the anemia.
  • This is the first reported case of concurrent feline PIMA and gastrointestinal lymphoma.

Implications:

  • This case highlights PIMA as a differential diagnosis for nonregenerative anemia in cats.
  • Concurrent PIMA and lymphoma may occur in felines.
  • Combined surgical and immunosuppressive treatment can be effective for these conditions.

Related Concept Videos